IL-17 Inhibition: A Valid Therapeutic Strategy in the Management of Hidradenitis Suppurativa

• Egile Nagusiak: Dalma Malvaso (Egilea), Laura Calabrese (Egilea), Andrea Chiricozzi (Egilea), Flaminia Antonelli (Egilea), Giulia Coscarella (Egilea), Pietro Rubegni (Egilea), Ketty Peris (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2023-10-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with a significant negative impact on the quality of life of patients. To date, the therapeutic landscape for the management of the disease has been extremely limited, resulting in a profound unmet need. Indeed, adalimumab, an anti...